提醒系统提高妊娠期糖尿病血糖记录依从性:系统综述与Meta分析
该系统综述与Meta分析纳入7项随机对照试验共863例妊娠期糖尿病患者,比较提醒系统(技术辅助或电话提醒)与无提醒系统的传统管理。提醒系统使血糖监测依从性提高(83.5% vs 68.2%;均差15.87,95%CI 10.94-20.80),平均血糖值降低(均差-5.63,95%CI -8.10至-3.15),剖宫产率降低(RR 0.66,95%CI 0.49-0.88);新生儿重症监护入住、巨大儿、大于胎龄儿及产后2小时糖耐量试验结果两组间无显著差异。
要点
- 提醒系统使血糖监测依从性由68.2%提高至83.5%(均差15.87,95%CI 10.94-20.80)。
- 提醒系统与平均血糖值降低相关(均差-5.63,95%CI -8.10至-3.15)。
- 提醒系统与剖宫产率降低相关(RR 0.66,95%CI 0.49-0.88)。
核心结论
- 对妊娠期糖尿病患者使用提醒系统可提高血糖监测依从性、降低平均血糖值,并与剖宫产风险降低相关。
研究设计与样本
- 系统综述与随机对照试验Meta分析,检索Scopus、PubMed、CINAHL和Cochrane Library自建库至2021年10月,最终纳入7项随机对照试验共863例患者。
- 纳入比较提醒系统(技术辅助或电话提醒)与无提醒系统传统管理的随机对照试验,排除仅报告定性结局或纳入孕前已患糖尿病者的研究,对照组含其他干预而非标准照护者亦被排除。
主要发现
- 提醒系统组血糖监测依从性83.5% vs 对照组68.2%(均差15.87,95%CI 10.94-20.80)。
- 提醒系统组平均血糖值较对照组降低(均差-5.63,95%CI -8.10至-3.15)。
- 提醒系统组剖宫产率低于对照组(RR 0.66,95%CI 0.49-0.88)。
- 新生儿重症监护入住、巨大儿、大于胎龄儿及产后2小时糖耐量试验结果两组间无显著差异。
关键数值与推荐
- 主要结局依从性定义为患者提供的血糖值数量除以指导监测的血糖值数量。
- 效应量以相对危险度或均差及95%置信区间报告。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We sought to evaluate the effectiveness of reminder systems in improving patient compliance with blood glucose level monitoring in gestational diabetes mellitus in a meta-analysis of randomized controlled trials. DATA SOURCES: Scopus, PubMed, CINAHL, and the Cochrane Library were searched from inception to October 2021. STUDY ELIGIBILITY CRITERIA: Randomized control trials that examined reminder-based systems (ie, technology assisted or phone based) to prompt pregnant patients with gestational diabetes mellitus to monitor blood glucose levels (compliance) vs traditional management without reminder systems were included. Studies were excluded if they examined only qualitative outcomes or examined patients with preexisting diabetes mellitus or those in which the control group included another intervention rather than standard care. METHODS: The primary outcome was patient compliance, defined as the number of blood glucose level values provided by the patient divided by the number of instructed blood glucose level values. The secondary outcomes were maternal mean blood glucose level values, 2-hour glucose tolerance test results after delivery, cesarean delivery rate, neonatal intensive care admission, and rates of large for gestational age or macrosomia. The summary measures were reported as relative risk or mean difference with a 95% confidence interval. RESULTS: Overall, 7 randomized controlled trials, including 863 patients, were included in our review. Reminder systems were associated with a statistically significant increase in patient compliance in blood glucose level monitoring (83.5% vs 68.2%; mean difference, 15.87; 95% confidence interval, 10.94-20.80). Reminder systems were associated with a significant decrease in mean blood glucose level values (mean difference, -5.63; 95% confidence interval, -8.10 to -3.15) and in the rate of delivery by cesarean delivery (relative risk, 0.66; 95% confidence interval, 0.49-0.88). Other outcomes, including neonatal intensive care unit admissions, fetal macrosomia, large for gestational age infants, and 2-hour glucose tolerance tests results after delivery were not substantial between the 2 groups. CONCLUSION: The use of reminder systems for patients with gestational diabetes mellitus increased patient compliance with blood glucose level monitoring, decreased mean blood glucose level values, and was associated with a decreased risk of cesarean delivery.
引用
- Horgan R, Pierce-Williams R, Saccone G, et al. Reminder systems to increase compliance with glucose logging in gestational diabetes: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2022. PMID: 35124298. doi:10.1016/j.ajogmf.2022.100586
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。